Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jacobs Solutions (J) Current Deferred Revenue (2016 - 2026)

Jacobs Solutions has reported Current Deferred Revenue over the past 13 years, most recently at $1.2 billion for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 14.6% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 14.6%, while the annual FY2025 figure was $940.6 million, 2.74% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $1.2 billion at Jacobs Solutions, up from $940.6 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $1.2 billion in Q4 2025 and troughed at $530.8 million in Q1 2021.
  • A 5-year average of $787.3 million and a median of $737.0 million in 2022 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 36.35% in 2024 and later fell 2.74% in 2025.
  • Year by year, Current Deferred Revenue stood at $605.8 million in 2021, then increased by 21.65% to $737.0 million in 2022, then grew by 28.35% to $945.9 million in 2023, then grew by 7.1% to $1.0 billion in 2024, then increased by 14.6% to $1.2 billion in 2025.
  • Business Quant data shows Current Deferred Revenue for J at $1.2 billion in Q4 2025, $940.6 million in Q3 2025, and $992.3 million in Q2 2025.